Evidence map›Paper›PMID 41291717›Full record

ArticleMalaria journal2025

Initiating community intermittent preventive treatment of malaria in pregnancy in Senegal: qualitative evaluation of stakeholder acceptability and experience.

Tidiane Ndoye, Maud Majeres Lugand, Abdoulaye Moussa Diallo, Seynabou Sakho, Mouhamadou Moustapha Pouye, Kadidiatou Dieng, Sylvain Landry B Faye

Erratum issuedAbstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tidiane Ndoye *Département de Sociologie, Université Cheikh Anta Diop, Fann, BP 5005, Dakar, Sénégal. tidiane.ndoye@ucad.edu.sn.
Maud Majeres Lugand *MMV Medicines for Malaria Venture, Geneva, Switzerland.
Abdoulaye Moussa DialloAfrican Population and Health Research Centre (APHRC), Dakar, Sénégal.
Seynabou SakhoDépartement de Sociologie, Université Cheikh Anta Diop, Fann, BP 5005, Dakar, Sénégal.
Mouhamadou Moustapha PouyeDépartement de Sociologie, Université Cheikh Anta Diop, Fann, BP 5005, Dakar, Sénégal.
Kadidiatou DiengDépartement de Sociologie, Université Cheikh Anta Diop, Fann, BP 5005, Dakar, Sénégal.
Sylvain Landry B FayeDépartement de Sociologie, Université Cheikh Anta Diop, Fann, BP 5005, Dakar, Sénégal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUptake of community delivery of intermittent preventive treatment for malaria in pregnancy (c-IPTp) with sulfadoxine-pyrimethamine (SP) has increased in Senegal, but further gains are needed. This qualitative study aimed to identify modifiable factors to enhance c-IPTp uptake and improve health outcomes for pregnant women in Senegal.

methodsThe study employed 111 semi-structured interviews and 16 focus group discussions to explore stakeholders' perspectives on c-IPTp in Senegal. Purposive sampling was used to select high malaria-endemic districts in Kolda and Kedougou. Inclusion criteria were experience of c-IPTp as a patient, caregiver, beneficiary, decision maker, or communicator/advocate (e.g., community leader). Individuals without experience in c-IPTp were excluded. Following thematic analysis, findings were synthesized into strengths, weaknesses, opportunities, and threats to inform the production of recommendations to promote and expand c-IPTp uptake in Senegal.

resultsHealth providers perceived c-IPTp positively, reducing their workload, allowing midwives to focus on other consultations, and addressing access issues in remote villages. However, some healthcare providers perceived that c-IPTp undermined attendance at antenatal care visits. Stockouts of SP and the unavailability of pregnancy tests were key barriers to uptake. Appropriate incentivization of community health workers was also a key factor for service delivery. Pregnant women found c-IPTp acceptable, appreciating the risks of malaria in pregnancy and perceiving SP to be effective. However, they expressed concerns regarding adverse events and socio-cultural issues around unplanned pregnancies. Key recommendations to strengthen c-IPTp delivery include ensuring supplies of SP and pregnancy tests, improving reporting mechanisms, incentivising community health workers, gaining acceptance from pregnant women, and securing consistent funding. It is also key that patient's individual needs are prioritized and that communities are fully involved in decision-making.

conclusionThe study identifies and addresses challenges to optimal deployment of c-IPTp in Senegal. Continued efforts to overcome these challenges will be crucial in realising the full potential of c-IPTp to improve maternal and child health outcomes in malaria-endemic regions.

Indexed as

AntimalarialsMalariaPatient Acceptance of Health CarePregnancy Complications, ParasiticPyrimethamineSulfadoxineAdultDrug CombinationsFemaleFocus GroupsHumansPregnancyQualitative ResearchSenegalYoung AdultAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineChemopreventionCommunityIntermittent preventive treatmentMalariaPregnancySulfadoxine–pyrimethamine

Identifiers

PMID41291717
PMCPMC12648916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.